Authors:
Green, PJ
Warre, R
Hayes, PD
McNaughton, NCL
Medhurst, AD
Pangalos, M
Duckworth, DM
Randall, AD
Citation: Pj. Green et al., Kinetic modification of the alpha(1I) subunit-mediated T-type Ca2+ channelby a human neuronal Ca2+ channel gamma subunit, J PHYSL LON, 533(2), 2001, pp. 467-478
Authors:
Meadows, HJ
Chapman, CG
Duckworth, DM
Kelsell, RE
Murdock, PR
Nasir, S
Rennie, G
Randall, AD
Citation: Hj. Meadows et al., The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK, BRAIN RES, 892(1), 2001, pp. 94-101
Authors:
Bromidge, SM
Dabbs, S
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Saunders, DV
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866
Authors:
Bromidge, SM
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870
Authors:
Hayes, P
Meadows, HJ
Gunthorpe, MJ
Harries, MH
Duckworth, DM
Cairns, W
Harrison, DC
Clarke, CE
Ellington, K
Prinjha, RK
Barton, AJL
Medhurst, AD
Smith, GD
Topp, S
Murdock, P
Sanger, GJ
Terrett, J
Jenkins, O
Benham, CD
Randall, AD
Gloger, IS
Davis, JB
Citation: P. Hayes et al., Cloning and functional expression of a human orthologue of rat vanilloid receptor-1, PAIN, 88(2), 2000, pp. 205-215
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gaster, LM
Ham, P
Jones, GE
King, FD
Mulholland, KR
Saunders, DV
Wyman, PA
Blaney, FE
Clarke, SE
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Trail, B
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134
Authors:
Lovell, PJ
Bromidge, SM
Dabbs, S
Duckworth, DM
Forbes, IT
Jennings, AJ
King, FD
Middlemiss, DN
Rahman, SK
Saunders, DV
Collin, LL
Hagan, JJ
Riley, GJ
Thomas, DR
Citation: Pj. Lovell et al., A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970), J MED CHEM, 43(3), 2000, pp. 342-345
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gadre, A
Ham, P
Jones, GE
King, FD
Saunders, DV
Thewlis, KM
Vyas, D
Blackburn, TP
Holland, V
Kennett, GA
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists, BIO MED CH, 7(12), 1999, pp. 2767-2773